Lahoutte T - Search Results

1

Plasma protein binding of luciferase substrates influences sensitivity and accuracy of bioluminescence imaging.

Keyaerts M, Heneweer C, Gainkam LO, Caveliers V, Beattie BJ, Martens GA, Vanhove C, Bossuyt A, Blasberg RG, Lahoutte T. Keyaerts M, et al. Among authors: lahoutte t. Mol Imaging Biol. 2011 Feb;13(1):59-66. doi: 10.1007/s11307-010-0325-x. Mol Imaging Biol. 2011. PMID: 20383591

2

In vitro characterization of the influx of 3-[125I]iodo-L-alpha-methyltyrosine and 2-[125I]iodo-L-tyrosine into U266 human myeloma cells: evidence for system T transport.

Lahoutte T, Caveliers V, Dierickx L, Vekeman M, Everaert H, Mertens J, Bossuyt A. Lahoutte T, et al. Nucl Med Biol. 2001 Feb;28(2):129-34. doi: 10.1016/s0969-8051(00)00184-0. Nucl Med Biol. 2001. PMID: 11295423

3

Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.

Dierickx LO, Lahoutte T, Deron P, Caveliers V, Vanhove C, Everaert H, Bossuyt A. Dierickx LO, et al. Among authors: lahoutte t. Eur J Nucl Med. 2001 Mar;28(3):282-7. doi: 10.1007/s002590000439. Eur J Nucl Med. 2001. PMID: 11315594 Clinical Trial.

4

Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.

Lahoutte T, Caveliers V, Franken PR, Bossuyt A, Mertens J, Everaert H. Lahoutte T, et al. J Nucl Med. 2002 Sep;43(9):1201-6. J Nucl Med. 2002. PMID: 12215559 Free article.

5

Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.

Caveliers V, Everaert H, John CS, Lahoutte T, Bossuyt A. Caveliers V, et al. Among authors: lahoutte t. J Nucl Med. 2002 Dec;43(12):1647-9. J Nucl Med. 2002. PMID: 12468514 Free article.

6

Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.

Dierickx LO, Everaert H, Deron P, Voordeckers M, Lahoutte T, Bossuyt A. Dierickx LO, et al. Among authors: lahoutte t. Nucl Med Commun. 2003 Jun;24(6):633-41. doi: 10.1097/00006231-200306000-00004. Nucl Med Commun. 2003. PMID: 12766598 Clinical Trial.

7

Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.

Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A. Lahoutte T, et al. J Nucl Med. 2003 Sep;44(9):1489-94. J Nucl Med. 2003. PMID: 12960197 Free article.

8

Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.

Everaert H, Vanhove C, Lahoutte T, Muylle K, Caveliers V, Bossuyt A, Franken PR. Everaert H, et al. Among authors: lahoutte t. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1615-9. doi: 10.1007/s00259-003-1317-8. Epub 2003 Sep 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14504831

9

Hypertrophic osteitis of the clavicle.

Everaert H, De Boeck H, Muylle K, Lahoutte T, Bossuyt A. Everaert H, et al. Among authors: lahoutte t. Clin Nucl Med. 2003 Dec;28(12):990-1. doi: 10.1097/01.rlu.0000099813.44188.7c. Clin Nucl Med. 2003. PMID: 14663326 No abstract available.

10

Synthesis, radiosynthesis, and in vitro characterization of [125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT.

Mertens J, Kersemans V, Bauwens M, Joos C, Lahoutte T, Bossuyt A, Slegers G. Mertens J, et al. Among authors: lahoutte t. Nucl Med Biol. 2004 Aug;31(6):739-46. doi: 10.1016/j.nucmedbio.2004.03.003. Nucl Med Biol. 2004. PMID: 15246364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters